miR-100 and miR-125b Contribute to Enhanced 3D Growth and Invasiveness and can be Functionally Transferred to Silence Target Genes in Recipient Cells

Hannah M. Nelson,Shimian Qu,Liyu Huang,Muhammad Shameer,Kevin C Corn,Sydney N. Chapman,Nicole L. Luthcke,Sara A. Schuster,Lauren A. Turnbull,Lucas L. Guy,Xiao Liu,Kasey C. Vickers,Qi Liu,Jeffrey L Franklin,Alissa Weaver,Marjan Rafat,Robert J. Coffey Jr.,James G Patton

DOI: https://doi.org/10.1101/2024.01.16.575716

2024-05-22

Abstract:Extracellular communication via the transfer of vesicles and nanoparticles is now recognized to play an important role in tumor microenvironment interactions. Cancer cells upregulate and secrete abundant levels of miR-100 and miR-125b that can alter gene expression by both cell- and non-cell-autonomous mechanisms. We previously showed that these miRNAs activate Wnt signaling in colorectal cancer (CRC) through noncanonical pairing with 5 negative regulators of Wnt signaling. To identify additional targets of miR-100 and miR-125b, we used bioinformatic approaches comparing multiple CRC cell lines, including knockout lines lacking one or both of these miRNAs. From an initial list of 96 potential mRNA targets, we tested 15 targets with 8 showing significant downregulation in the presence of miR-100 and miR-125b. Among these, Cingulin (CGN) and Protein tyrosine phosphatase receptor type-R (PTPRR) are downregulated in multiple cancers, consistent with regulation by increased levels of miR-100 and miR-125b. We also show that increased cellular levels of miR-100 and miR-125b enhance 3D growth and invasiveness in CRC and glioblastoma cell lines. Lastly, we demonstrate that extracellular transfer of miR-100 and miR-125b can silence both reporter and endogenous mRNA targets in recipient cells and also increase the invasiveness of recipient spheroid colonies when grown under 3D conditions in type I collagen.

Cancer Biology

What problem does this paper attempt to address?

### What problem does this paper attempt to solve?

This paper primarily explores the mechanisms of action of miR-100 and miR-125b in colorectal cancer (CRC) and other cancers, specifically including the following aspects:

1. **Identifying new targets of miR-100 and miR-125b**:
- Using bioinformatics analysis to compare multiple colorectal cancer cell lines, including cell lines with miR-100 and miR-125b knocked out, to identify potential mRNA targets.
- From an initial screening of 96 potential targets, 15 targets were tested, and 8 were found to be significantly downregulated.

2. **Validating the functional transfer of miR-100 and miR-125b**:
- Using CRISPR/Cas9 technology to create cell lines with miR-100, miR-125b, or both knocked out to confirm whether the transfer of miRNA leads to target gene silencing.
- Through Transwell co-culture experiments, it was demonstrated that miR-100 and miR-125b can transfer from donor cells to recipient cells, leading to the silencing of reporter genes and endogenous genes in recipient cells.

3. **Studying the impact of miR-100 and miR-125b on 3D growth and invasiveness**:
- It was found that the increase of miR-100 and miR-125b can enhance the 3D growth and invasiveness of colorectal cancer and glioblastoma cells.
- Special attention was given to Cingulin (CGN) and Protein tyrosine phosphatase receptor type-R (PTPRR), two targets that are downregulated in various cancers and are consistent with the high expression of miR-100 and miR-125b.

4. **Validating the expression changes of Cingulin in colorectal cancer**:
- Using Western blot and immunofluorescence staining to validate the changes in Cingulin protein levels, the results showed a significant reduction of Cingulin in cells with high expression of miR-100 and miR-125b.

Through these studies, the paper aims to reveal the mechanisms by which miR-100 and miR-125b contribute to cancer progression, particularly how they promote tumor invasiveness and metastatic potential by regulating target genes.